UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 .

 

Commission File Number  000-31633

 

Kosan Biosciences Incorporated

(Exact name of registrant as specified in its charter)

 

3832 Bay Center Place, Hayward, CA 94545   (510) 732-8400

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.001 par value

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)(i)

x

 

Rule 12h-3(b)(1)(i)

x

 

 

Rule 12g-4(a)(1)(ii)

o

 

Rule 12h-3(b)(1)(ii)

o

 

 

Rule 12g-4(a)(2)(i)

o

 

Rule 12h-3(b)(2)(i)

o

 

 

Rule 12g-4(a)(2)(ii)

o

 

Rule 12h-3(b)(2)(ii)

o

 

 

 

 

 

Rule 15d-6

o

 

 

Approximate number of holders of record as of the certification or notice date: One

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Kosan Biosciences Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

 

 

Kosan Biosciences Incorporated

 

 

 

 

 

 

 

Date:

June 26, 2008

 

By:

/s/ Jeremy Levin

 

 

 

 

Name:

Jeremy Levin

 

 

 

 

Title:

President

 

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

SEC 2069 (12-04)

 

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 


Kosan Biosciences (MM) (NASDAQ:KOSN)
過去 株価チャート
から 5 2024 まで 6 2024 Kosan Biosciences (MM)のチャートをもっと見るにはこちらをクリック
Kosan Biosciences (MM) (NASDAQ:KOSN)
過去 株価チャート
から 6 2023 まで 6 2024 Kosan Biosciences (MM)のチャートをもっと見るにはこちらをクリック